484 related articles for article (PubMed ID: 29665840)
1. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
[TBL] [Abstract][Full Text] [Related]
2. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.
Orban JC; Quintard H; Cassuto E; Jambou P; Samat-Long C; Ichai C
Transplantation; 2015 Apr; 99(4):746-53. PubMed ID: 25250647
[TBL] [Abstract][Full Text] [Related]
3. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.
Sun Q; Hong L; Huang Z; Na N; Hua X; Peng Y; Zhao M; Cao R; Sun Q
Trials; 2017 Nov; 18(1):545. PubMed ID: 29145879
[TBL] [Abstract][Full Text] [Related]
5. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
Trials; 2020 May; 21(1):428. PubMed ID: 32450917
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
Jordan SC; Choi J; Aubert O; Haas M; Loupy A; Huang E; Peng A; Kim I; Louie S; Ammerman N; Najjar R; Puliyanda D; Vo A
Am J Transplant; 2018 Dec; 18(12):2955-2964. PubMed ID: 29637714
[TBL] [Abstract][Full Text] [Related]
7. Daclizumab (humanized anti-IL2Ralpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function.
Bumgardner GL; Ramos E; Lin A; Vincenti F;
Transplantation; 2001 Aug; 72(4):642-7. PubMed ID: 11544424
[TBL] [Abstract][Full Text] [Related]
8. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
[TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
Jafari A; Khatami MR; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi A; Moghaddas A
J Ren Nutr; 2017 Mar; 27(2):113-126. PubMed ID: 28065453
[TBL] [Abstract][Full Text] [Related]
11. Delayed Graft Function Phenotypes and 12-Month Kidney Transplant Outcomes.
Hall IE; Reese PP; Doshi MD; Weng FL; Schröppel B; Asch WS; Ficek J; Thiessen-Philbrook H; Parikh CR
Transplantation; 2017 Aug; 101(8):1913-1923. PubMed ID: 27495761
[TBL] [Abstract][Full Text] [Related]
12. Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation.
Alvarez S; Suazo C; Boltansky A; Ursu M; Carvajal D; Innocenti G; Vukusich A; Hurtado M; Villanueva S; Carreño JE; Rogelio A; Irarrazabal CE
Transplant Proc; 2013; 45(10):3719-23. PubMed ID: 24315007
[TBL] [Abstract][Full Text] [Related]
13. Vasopressor selection during critical care management of brain dead organ donors and the effects on kidney graft function.
Swanson EA; Patel MS; Groat T; Jameson NE; Ellis MKM; Hutchens MP; Niemann CU; Malinoski DJ; Sally MB
J Trauma Acute Care Surg; 2020 Jun; 88(6):783-788. PubMed ID: 32459446
[TBL] [Abstract][Full Text] [Related]
14. Effect of Delayed Graft Function on the Outcome and Allograft Survival of Kidney Transplanted Patients from a Deceased Donor.
Maia LF; Lasmar MF; Fabreti-Oliveira RA; Nascimento E
Transplant Proc; 2021 Jun; 53(5):1470-1476. PubMed ID: 34006380
[TBL] [Abstract][Full Text] [Related]
15. Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials.
Schröppel B; Akalin E; Baweja M; Bloom RD; Florman S; Goldstein M; Haydel B; Hricik DE; Kulkarni S; Levine M; Mehrotra A; Patel A; Poggio ED; Ratner L; Shapiro R; Heeger PS
Am J Transplant; 2020 Feb; 20(2):564-572. PubMed ID: 31452319
[TBL] [Abstract][Full Text] [Related]
16. The impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation.
Shin JH; Koo EH; Ha SH; Park JH; Jang HR; Lee JE; Park JB; Kim SJ; Jung SH; Kim YG; Kim DJ; Oh HY; Huh W
Int Urol Nephrol; 2016 Mar; 48(3):431-9. PubMed ID: 26581566
[TBL] [Abstract][Full Text] [Related]
17. Effect of intraoperative human albumin on early graft function in renal transplantation.
Shah RB; Shah VR; Butala BP; Parikh GP
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1148-53. PubMed ID: 25394429
[TBL] [Abstract][Full Text] [Related]
18. Prediction models for delayed graft function: external validation on The Dutch Prospective Renal Transplantation Registry.
Kers J; Peters-Sengers H; Heemskerk MBA; Berger SP; Betjes MGH; van Zuilen AD; Hilbrands LB; de Fijter JW; Nurmohamed AS; Christiaans MH; Homan van der Heide JJ; Debray TPA; Bemelman FJ
Nephrol Dial Transplant; 2018 Jul; 33(7):1259-1268. PubMed ID: 29462353
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and consequences of delayed graft function.
Ounissi M; Cherif M; Abdallah TB; Bacha M; Hedri H; Abderrahim E; Goucha R; Kheder A; Slama RB; Derouiche A; Chebil M; Bardi R; Sfar I; Gorgi Y
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):243-6. PubMed ID: 23538345
[TBL] [Abstract][Full Text] [Related]
20. Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial.
Kainz A; Wilflingseder J; Mitterbauer C; Haller M; Burghuber C; Perco P; Langer RM; Heinze G; Oberbauer R
Ann Intern Med; 2010 Aug; 153(4):222-30. PubMed ID: 20713790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
